持続的な不眠症に対する認知行動療法,単独および薬剤との併用:ランダム化制御試験
Charles M Morin1, Annie Vallières, Bernard Guay
1Université Laval, Ecole de Psychologie, Pavillon F A S, Québec, Québec, Canada G1K 0A6. cmorin@psy.ulaval.ca
JAMA
|May 21, 2009
まとめ
認知行動療法 (CBT) に薬を追加することで,短期的な不眠が改善されたが,メンテナンスCBT中に薬を中止すると,不眠が持続する患者の長期的なアウトカムが最適化された.
科学分野:
- スリープ・メディシン (睡眠医学)
- 行動療法とは行動療法です.
- 薬理学 薬理学とは
背景:
- 認知行動療法 (CBT) と催眠薬は短期的な不眠治療に有効ですが,完全な寛解はまれです.
- 不眠症の併用療法や維持療法の最適なアプローチは不明である.
研究 の 目的:
- 急性不眠症の治療のためにCBTに薬剤を追加するメリットを評価する.
- 不眠症の結果に対する維持療法の長期的な効果を決定する.
主な方法:
- 持続的な不眠症を持つ160人の成人を対象とした前向きなランダム化比較試験です.
- 2段階の治療:最初の6週間の治療 (CBT単独 vs CBT + ゾルピデム),その後6ヶ月の延長治療.
- 結果には,睡眠パラメータ (遅延,覚醒時間,睡眠総量,効率) と治療応答/寛解率が含まれていました.
主要な成果:
- CBT単独およびCBTとゾルピデムの両方が,急性治療中に不眠症を大幅に改善しました.
- 組み合わせた治療は,6ヶ月の延長治療とフォローアップの間,CBT単独よりも高い寛解率を示しました.
- 維持CBT中にゾルピデム投与を中止すると,長期的な寛解率が最も高くなりました.
結論:
- ゾルピデムをCBTに添加すると,持続的な不眠症に対する急性利益が得られます.
- 長期的な不眠症の結果は,維持CBT中に薬の投与を中止することで最適化され,CBTのみを好む.
さらに関連する動画
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
関連する概念動画
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...